Therapeutic Success of Rifaximin for Clostridium difficile Infection Refractory to Metronidazole and Vancomycin

Therapeutic Success of Rifaximin for Clostridium difficile Infection Refractory to Metronidazole and Vancomycin

We report the case of a 46-year-old white male with confirmed Clostridium difficile infection for >4 weeks after fluoroquinolone therapy. The patient received two courses of metronidazole 500 mg three times daily (t.i.d.) during which time diarrhea resolved; however, symptoms recurred 14–15 days...

Full description

Bibliographic Details
Main Authors: George Tannous, Guy Neff, Nyingi Kemmer
Format: Article
Language:English
Published: Karger Publishers 2010-09-01
Series:Case Reports in Gastroenterology
Subjects:
Recurrent Clostridium difficile infection
Rifaximin
Vancomycin2
Metronidazole2
Saccharomyces boulardii
Online Access:http://www.karger.com/Article/FullText/320685

Internet

http://www.karger.com/Article/FullText/320685

Similar Items